[Early biochemical failure after radical prostatectomy for prostate cancer. Impact factors?].
Does delay from biopsy to surgery have any influence?


OBJECTIVE
To determine wether WT may impact on the EBF (before one year) alter RRP in our series, and to study other factors that may impact on this issue.


METHODS
We study 310 RRP. Inclusion criteria are: one year follow up, no hormonal manipulation neither previous radiotherapy. Patients are divide in two groups attending WT. Group A < 90 days (n: 148), Group B > 90 days (n: 162). We study EBF (2 or more PSA determinations >= 0.2 ng/ml), and the impact of previous PSA, biopsy Gleason, Gleason of the specimen (G), pT stage (pT), and WT. T of Student or W of Wilcoxon are used to determine the homogeneity of the two groups. Chi Square of Pearson to compare the two group's EBF and pT attending to WT and EBF attending to pT. U of Mann Whitney is used to study EBF attending to G. Multivariate logistic regresion (LR) is used to study the impact of the variables on EBF.


RESULTS
There are no differences between the two groups in age (p<0.129), PSA (p<0.479), biopsy's Gleason (p<0.913). There are no differences in EBF nor in pT attending to WT. Significant statystical differences are founded in EBF attending to pT and G. T3 tumors have more chance of recurrence than T2. EBF is more frecuent as G increases. In logistic regresion of the global serie, independent variables for progression are: Previous PSA and pT. Nor biopsy's Gleason nor specimen's Gleason, nor WT, impact on the EBF.


CONCLUSIONS
Biopsy Gleason and WT do not impact on EBF. WT do not impact on pT. In our serie differences on EBF are lead by previous PSA and pT. Also Gleason of the especimen seems to impact on EBF, but in lower proportion, with no significance in multivariate analysis.
Servicio de Urología, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria. abdiez2003@yahoo.es
A
A
Blanco Díez
J
J
Armas Molina
J M
JM
Limiñana Canal
C
C
Jiménez García
J L
JL
Artíles Hernández
N
N
Chesa Ponce
D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000601:surgery*; D012189:Retrospective Studies; D013997:Time Factors; D017211:Treatment Failure
D017430:Prostate-Specific Antigen